2022 Oncology Biosimilar Guide to Patient Support Services

Viatris is a leading global provider of biosimilars and has received regulatory approvals in more than 85 countries. The company’s biosimilars franchise is focused on the areas of oncology, immunology, endocrinology, ophthalmology, and dermatology. These products can help increase access for current and future patients while supporting the sustainability of healthcare systems. Read More ›

Amgen offers assistance to patients through Amgen Assist 360, Amgen FIRST STEP, and the Amgen Safety Net Foundation. Read More ›

Coherus BioSciences’ Coherus COMPLETE offers comprehensive reimbursement and support services for patients receiving treatment with Udenyca (pegfilgrastim-cbqv) who are unable to afford this medication. The program also offers provider coding and billing services to facilitate appropriate billing and reimbursement. Read More ›

The Organon Access Program can help answer questions about benefit investigations, the Organon Co-pay Assistance Program, and eligibility determination for referrals to the Organon Patient Assistance Program. Read More ›

Pfizer offers Pfizer Oncology Together, a patient support program to help patients access their prescribed Pfizer Oncology medications, identify financial assistance options, and connect patients to a dedicated Care Champion. Read More ›

Sandoz, a Novartis Division, offers the Sandoz One Source patient support program to assist patients while taking Zarxio or Ziextenzo. Read More ›

Teva Oncology offers the Comprehensive Oncology Reimbursement Expertise (CORE) program and the Teva Cares Foundation Patient Assistance Program to help patients while taking a Teva Oncology treatment. Read More ›